Literature DB >> 30559475

GABA and glutamate neurons in the VTA regulate sleep and wakefulness.

Xiao Yu1, Wen Li2, Ying Ma1, Kyoko Tossell1, Julia J Harris1,3, Edward C Harding1, Wei Ba1, Giulia Miracca1, Dan Wang2, Long Li2, Juan Guo2, Ming Chen4, Yuqi Li1, Raquel Yustos1, Alexei L Vyssotski5, Denis Burdakov3, Qianzi Yang2, Hailong Dong6, Nicholas P Franks7,8,9, William Wisden10,11,12.   

Abstract

We screened for novel circuits in the mouse brain that promote wakefulness. Chemogenetic activation experiments and electroencephalogram recordings pointed to glutamatergic/nitrergic (NOS1) and GABAergic neurons in the ventral tegmental area (VTA). Activating glutamatergic/NOS1 neurons, which were wake- and rapid eye movement (REM) sleep-active, produced wakefulness through projections to the nucleus accumbens and the lateral hypothalamus. Lesioning the glutamate cells impaired the consolidation of wakefulness. By contrast, activation of GABAergic VTA neurons elicited long-lasting non-rapid-eye-movement-like sleep resembling sedation. Lesioning these neurons produced an increase in wakefulness that persisted for at least 4 months. Surprisingly, these VTA GABAergic neurons were wake- and REM sleep-active. We suggest that GABAergic VTA neurons may limit wakefulness by inhibiting the arousal-promoting VTA glutamatergic and/or dopaminergic neurons and through projections to the lateral hypothalamus. Thus, in addition to its contribution to goal- and reward-directed behaviors, the VTA has a role in regulating sleep and wakefulness.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30559475      PMCID: PMC6390936          DOI: 10.1038/s41593-018-0288-9

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  67 in total

Review 1.  Nitric oxide signalling in the brain and its control of bodily functions.

Authors:  Konstantina Chachlaki; Vincent Prevot
Journal:  Br J Pharmacol       Date:  2019-09-08       Impact factor: 8.739

2.  Precise Coordination of Three-Dimensional Rotational Kinematics by Ventral Tegmental Area GABAergic Neurons.

Authors:  Ryan N Hughes; Glenn D R Watson; Elijah A Petter; Namsoo Kim; Konstantin I Bakhurin; Henry H Yin
Journal:  Curr Biol       Date:  2019-09-26       Impact factor: 10.834

Review 3.  A role for the neuropeptide somatostatin in the neurobiology of behaviors associated with substances abuse and affective disorders.

Authors:  Stacey L Robinson; Todd E Thiele
Journal:  Neuropharmacology       Date:  2020-02-03       Impact factor: 5.250

4.  The neuroanatomy and neurochemistry of sleep-wake control.

Authors:  Heinrich S Gompf; Christelle Anaclet
Journal:  Curr Opin Physiol       Date:  2019-12-31

5.  Activation of Dopamine Signals in the Olfactory Tubercle Facilitates Emergence from Isoflurane Anesthesia in Mice.

Authors:  Bo Yang; Yawen Ao; Ying Liu; Xuefen Zhang; Ying Li; Fengru Tang; Haibo Xu
Journal:  Neurochem Res       Date:  2021-03-12       Impact factor: 3.996

6.  Natural and Drug Rewards Engage Distinct Pathways that Converge on Coordinated Hypothalamic and Reward Circuits.

Authors:  Amber L Alhadeff; Nitsan Goldstein; Onyoo Park; Michelle L Klima; Alexandra Vargas; J Nicholas Betley
Journal:  Neuron       Date:  2019-07-02       Impact factor: 17.173

Review 7.  Arousal and sleep circuits.

Authors:  Barbara E Jones
Journal:  Neuropsychopharmacology       Date:  2019-06-19       Impact factor: 7.853

8.  Sleep and Neuroimaging.

Authors:  Kyoungjune Pak; Jiyoung Kim; Keunyoung Kim; Seong Jang Kim; In Joo Kim
Journal:  Nucl Med Mol Imaging       Date:  2020-04-15

9.  Activation of Preoptic Tachykinin 1 Neurons Promotes Wakefulness over Sleep and Volatile Anesthetic-Induced Unconsciousness.

Authors:  Sarah L Reitz; Andrzej Z Wasilczuk; Gretel H Beh; Alex Proekt; Max B Kelz
Journal:  Curr Biol       Date:  2020-11-13       Impact factor: 10.834

10.  The brain rhythms that detach us from reality.

Authors:  Ken Solt; Oluwaseun Akeju
Journal:  Nature       Date:  2020-10       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.